Qiang Wang

机构：Houston Methodist, Affiliated Hospital of Guilin Medical College · ORCID：0000-0002-6141-0068

发表论文 148 篇 · 总被引 5150 次 · h-index 34

代表论文

• Astrocyte‐Derived Extracellular Vesicular miR‐143‐3p Dampens Autophagic Degradation of Endothelial Adhesion Molecules and Promotes Neutrophil Transendothelial Migration after Acute Brain Injury (2023 · Advanced Science · 被引 35)
• Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis (2024 · Nature Communications · 被引 34)
• Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors (2025 · Journal for ImmunoTherapy of Cancer · 被引 11)
• Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial (2025 · Cancer Immunology Immunotherapy · 被引 10)
• Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers (2024 · Journal for ImmunoTherapy of Cancer · 被引 8)
• Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss (2025 · Nature Cancer · 被引 6)